Last reviewed · How we verify

NCT05036356

Burnout Reduction and Engagement App-based Trial of Headspace (BREATHE)

Completed NA Last updated 9 December 2022
What this trial tests

NA trial testing Headspace App in Burnout, Professional in 66 participants. Completed in 5 August 2022.

Timeline
2 November 2021
Primary endpoint
5 August 2022
5 August 2022

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment66
Start date2 November 2021
Primary completion5 August 2022
Estimated completion5 August 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

21 and older, any sex, with Burnout, Professional. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research is to develop a mobile app-based intervention to reduce burnout and improve well-being using human-centered design principles and stakeholder feedback.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Burnout, Professional

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05036356.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing